AirSculpt Technologies, Inc. (NASDAQ:AIRS) Sees Significant Growth in Short Interest

AirSculpt Technologies, Inc. (NASDAQ:AIRS) was the target of a large growth in short interest in November. As of November 15th, there was short interest totalling 1,820,000 shares, a growth of 15.2% from the October 31st total of 1,580,000 shares. Based on an average daily trading volume, of 143,600 shares, the short-interest ratio is presently 12.7 days. Currently, 14.9% of the shares of the company are sold short.

AirSculpt Technologies Trading Up 2.9 %

AirSculpt Technologies stock opened at $6.83 on Monday. The stock has a market cap of $395.32 million, a P/E ratio of -48.79 and a beta of 1.57. AirSculpt Technologies has a fifty-two week low of $2.92 and a fifty-two week high of $9.20. The firm’s fifty day moving average price is $6.10 and its 200-day moving average price is $4.85. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.51 and a current ratio of 0.51.

AirSculpt Technologies (NASDAQ:AIRS) last released its quarterly earnings results on Friday, November 8th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.05). The business had revenue of $42.55 million during the quarter, compared to analysts’ expectations of $42.49 million. AirSculpt Technologies had a negative net margin of 4.13% and a positive return on equity of 2.22%. During the same period in the previous year, the business earned ($0.01) EPS. Equities research analysts forecast that AirSculpt Technologies will post 0.08 earnings per share for the current fiscal year.

Insider Activity at AirSculpt Technologies

In other AirSculpt Technologies news, CEO Dennis Dean sold 24,510 shares of the firm’s stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $6.54, for a total value of $160,295.40. Following the completion of the transaction, the chief executive officer now owns 582,052 shares in the company, valued at $3,806,620.08. This trade represents a 4.04 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 78.77% of the stock is owned by company insiders.

Hedge Funds Weigh In On AirSculpt Technologies

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Barclays PLC raised its position in shares of AirSculpt Technologies by 227.0% during the 3rd quarter. Barclays PLC now owns 19,100 shares of the company’s stock valued at $97,000 after buying an additional 13,259 shares in the last quarter. Geode Capital Management LLC raised its position in AirSculpt Technologies by 6.4% during the third quarter. Geode Capital Management LLC now owns 355,540 shares of the company’s stock valued at $1,803,000 after purchasing an additional 21,339 shares in the last quarter. SW Investment Management LLC lifted its stake in AirSculpt Technologies by 5.0% during the second quarter. SW Investment Management LLC now owns 4,500,000 shares of the company’s stock worth $18,000,000 after purchasing an additional 213,677 shares during the last quarter. Finally, Vanguard Group Inc. boosted its holdings in shares of AirSculpt Technologies by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 576,038 shares of the company’s stock worth $3,537,000 after purchasing an additional 5,606 shares in the last quarter. Hedge funds and other institutional investors own 91.54% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, BTIG Research started coverage on shares of AirSculpt Technologies in a research report on Thursday, October 17th. They issued a “neutral” rating for the company.

About AirSculpt Technologies

AirSculpt Technologies, Inc, together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.